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Panax notoginseng (Burk.) F. H. Chen is a medicinal herb used to treat blood disorders
since ancient times, of which the steamed form exhibits the anti-anemia effect and acts
with a “blood-tonifying” function according to traditional use. The present study aimed
to investigate the anti-anemia effect and underlying mechanism of steamed P.
notoginseng (SPN) on mice with blood deﬁciency syndrome induced by chemotherapy.
Blood deﬁciency syndrome was induced in mice by cyclophosphamide and
acetylphenylhydrazine. A number of peripheral blood cells and organs (liver, kidney, and
spleen) coefﬁcients were measured. The mRNA expression of hematopoietic function-
related cytokines in the bone marrow of mice was detected by RT-qPCR. The janus
kinase-signal transducer and activator of transcription (JAK-STAT) signaling pathway was
screened based on our previous analysis by network pharmacology. The expression of
related proteins and cell cycle factors predicted in the pathway was determined by
Western blot and RT-qPCR. SPN could signiﬁcantly increase the numbers of peripheral
blood cells and reverse the enlargement of spleen in a dose-dependent manner. The
quantities of related hematopoietic factors in bone marrow were also increased
signiﬁcantly after SPN administration. SPN was involved in the cell cycle reaction and
activation of immune cells through the JAK-STAT pathway, which could promote
the hematopoiesis.
Keywords: steamed Panax notoginseng, network pharmacology, JAK-STAT signaling pathway, anemia, blood
deﬁciency syndrome, hematopoiesisAbbreviations: APH, acetyl phenylhydrazine; Bcl-2, B-cell lymphoma-2; BDS, blood deﬁciency syndrome; c-Mpl,
thrombopoietin receptor; c-Myc, v-myc avian myelocytomatosis viral oncogene homolog; CY, cyclophosphamide; EPO,
erythropoietin; EPOR, erythropoietin receptor; FEJ, Fufang E'jiao Jiang; GM-CSF, granulocyte-macrophage colony-
stimulating factor; Hb, hemoglobin; IL-2, interleukin-2; JAK-STAT, janus kinase-signal transducer and activator of
transcription; KEGG, Kyoto Encyclopedia of Genes and Genomes; PN, Panax notoginseng; PLT, platelet; RBC, red blood
cell; PT-qPCR, real-time quantitative polymerase chain reaction; SHP-2, tyrosine-protein phosphatase non-receptor type 11;
SPN, steamed Panax notoginseng; TPO, thrombopoietin; WBC, white blood cell.
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Blood deﬁciency, a common syndrome seen in the clinic, is a
pathological state of blood dysfunction and organs dystrophy
according to the theory of traditional Chinese medicine (Li et al.,
2015a). The diagnostic indicator of blood deﬁciency syndrome
(BDS) mainly refers to the reduction of blood cells or
hemoglobin, which is similar as anemia in modern medicine.
Patients or animals with BDS often suffer from impaired
hemopoietic function, peripheral blood pancytopenia,
hypofunction of internal organs, malnutrition, or even
myelosuppression during severe diseases (Zhang et al., 2014a;
Ji et al., 2017). To ﬁnd therapies to alleviate BDS and treat
anemia has attracted tremendous attention in recent years.
Hematopoietic cytokines, such as granulocyte-macrophage
colony-stimulating factor (GM-CSF), interleukin-2 (IL-2),
erythropoietin (EPO), and thrombopoietin (TPO), are
sometimes used to accelerate the hemopoietic recovery during
cancer therapy. However, due to the unstable efﬁcacy, high cost,
and adverse effects like osteomuscular pain, arthralgia, and
allergic reactions (Dygai et al., 2012) caused by those
treatments, the applications of above compounds regimens
are limited.
It was reported that many Chinese herbal medicines with
efﬁcacies of enriching and regulating blood, could prevent and
treat BDS as well as anemia (Li et al., 2012; Chen J. et al., 2019; Li
et al., 2015b). Panax notoginseng (PN) Burk., a plant in genus
Panax (Araliaceae), is a highly valued Chinese herbal medicine
used to treat blood disorders in Asia for thousands of years
(Wang et al., 2006). It was recorded in “Supplements for
Compendium of Materia Medica” (1786) by Xue Min Zhao as
such that PN root could be used as a hematinic drug (Guo et al.,
2010). A steaming process is often used to enhance the “blood-
tonifying” function of PN (Lau et al., 2003). According to our
previous study, along with the duration of steaming, the levels of
some major active saponins in raw PN were decreased and some
other new saponins were produced or increased (Xiong et al.,
2017a; Xiong et al., 2017b). Such transformation of active
constituents in raw and steamed PN (SPN) contributes to the
difference in their efﬁcacies, such as that SPN is better at
nourishing the blood and supplementing qi (vital energy) (The
State Pharmacopoeia Commission of People's Republic, 2005;
Xiong et al., 2017b). Although multiple pharmaceutic studies
have been carried out to conﬁrm the therapeutic effect of SPN on
BDS (The State Pharmacopoeia Commission of People's
Republic, 2005; Zhou et al., 2014; Xiong et al., 2017a; Xiong
et al., 2017b), the underlying action mechanism is still unclear,
which hinders the development of anti-anemia drugs from this
herbal medicine of which side effects are only rarely reported.
To better elucidate the mechanism of SPN treating BDS, the
classical BDS model induced by acetyl phenylhydrazine (APH)
and cyclophosphamide (CY) was used in this study (Zhang et al.,
2014a). Based on our previous analysis of the possible signaling
pathways related to the hematinic effect of SPN using the
network pharmacology, the janus kinase-signal transducer and
activator of transcription (JAK-STAT) signaling pathway wasFrontiers in Pharmacology | www.frontiersin.org 2chosen to further elucidate since it was predicted to be one of the
pathways with a large number of potential targets involved
(Figure S1) (Xiong et al., 2019). The pathway involves many
members of the cytokine receptor superfamily, including GM-
CSF, EPO, TPO, interferons, and numerous interleukins, which
makes it central to hematopoietic cell biology and hematologic
therapy alike (Darnell et al., 1994; Ward et al., 2000). In this
study, based on the classical BDS mice model, the hematopoietic
effect and working mechanism of SPN were investigated by
evaluating the routine blood parameters, organ coefﬁcients,
and hematopoiesis-related factors involved in the JAK-STAT
pathway. These data provide a theoretical basis for the use of
SPN and its products in human health and provides clues for
developing new drugs to treat BDS as well as anemia.MATERIALS AND METHODS
Preparation and Chemical Analysis of
Steamed Panax notoginseng
Samples were collected from Wenshan, Yunnan in China (104°
077ˊE, 23°188ˊN), which were identiﬁed to be the dried root and
rhizome of P. notoginseng (Burkill) F. H. Chen by Prof. Xiuming
Cui from Kunming University of Science and Technology. The
specimen (No. WSPN15101) is deposited in Yunnan Key
Laboratory of P. notoginseng, Kunming University of Science
and Technology (Figure S2), which can be fully validated
using http://mpns.kew.org/mpns-portal/?_ga=1.111763972.
1427522246.1459077346. And the quality of samples was
consistent with the requirements of Chinese Pharmacopoeia of
2015 edition (Chinese Pharmacopoeia Commission, 2015). The
preparation of SPN was described in our previous study (Xiong
et al., 2017b). In short, SPN samples were prepared by steaming
the crushed raw materials in an autoclave (Shanghai Boxun
Industry and Commerce Co., Ltd, China) for 6 h at 120°C. The
steamed powder was then dried in a heating-air drying oven at
about 45°C to constant weight, then powdered and sieved
through a 40-mesh sieve.
Qualitative and quantitative analyses of SPN were performed
as previous report (Xiong et al., 2017a). In brief, notoginsenoside
R1 and ginsenosides Rg1, Re, 20(R)-Rh1, Rb1, Rd, Rk3, Rh4, 20(S)-
Rg3, 20(R)-Rg3 (Sichuan Weikeqi Biological Technology Co.,
Ltd. Sichuan, China) with purity ≧ 98% were used as standard
compounds. The analysis was performed on an Agilent
1260HPLC system (Agilent Technologies) equipped with a
G1311B Pump, a G4212B DAD detector, and a G1329B
autosampler. Chromatographic separation was carried out at
30°C on a Vision HT C18 column (250 × 4.6 mm, 5mm). The
mobile phase was comprised of A (ultra pure water) and B
(methyl cyanide). The gradient mode was as follows: 0–20 min,
80% A; 20–45 min, 54% A; 45–55 min, 45% A; 55–60 min, 45%
A; 60–65 min, 100% B; 65–70 min, 80% A; 70–90 min, 80% A.
The ﬂow rate was set at 1.0 ml/min. The detection wavelength
was set at 203 nm and sample volume was set at 10 ml. The HPLC
chromatogram of SPN sample and chemical structures of
dominating compounds characterized were shown in Figure S3.January 2020 | Volume 10 | Article 1578
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Animal experimental procedures in the study were strictly
conform the Guide for the Care and Use of Laboratory
Animals and related ethics regulations of Kunming University
of Science and Technology. The protocol was approved by the
Experimental Animal Welfare and Ethics Committee, Kunming
University of Science and Technology. Sixty Kunming (KM)
mice, half male and half female, weighing 18–22 g, were
purchased from Tianqin Biotechnology Co. Ltd., Changsha,
China [SCXK (Xiang) 2014-0011].
Mice were randomly divided into six groups, namely the
control group, model group, Fufang E'jiao Jiang (FEJ) group,
high-dose SPN (H-SPN) group, moderate-dose SPN (M-SPN)
group, and low-dose SPN (L-SPN) group, 10 mice in each group
(the power analysis to determine the sample size was given in
Table S1). The experimental method was described in our
previous study (Xiong et al., 2017a). “The BDS model was
established by intraperitoneal injection of 0.07 g·kg-1 of CY for
the ﬁrst 3 days and a hypodermic injection of 0.02 g·kg-1 of APH
on the fourth day. After that, mice in the control group were
administered with 0.9% normal saline, whereas other groups were
administered with FEJ (8 ml/kg-1), or SPN powder (1.8, 0.90, and
0.45 g·kg-1, respectively), respectively, by gavage for 12 days.”
Blood Routine Test
Half an hour after the last experimental administration (saline,
FEJ, or SPN), the mice were slightly anesthetized with a small
amount of diethyl ether, and blood was taken from the orbit and
collected into a sterile centrifuge tube containing sodium citrate.
Blood was subjected to a peripheral hemogram analysis by a
HEMAVET 950 ful l-automatic blood cel l analyzer
(DrewScient iﬁc Group, Dal las , TX, USA), for the
quantiﬁcation of red blood cells (RBCs), white blood cells
(WBCs), hemoglobin (Hb) and platelets (PLTs).
Organ Coefﬁcient
After the anesthetization and blood collection as described in 2.3,
the mice were sacriﬁced by cervical dislocation. The liver, kidney,
and spleens were washed in normal saline solution, dried with
ﬁlter paper, and weighed immediately. The spleens were stored in
liquid nitrogen for Western blot analysis. Organ coefﬁcient wasFrontiers in Pharmacology | www.frontiersin.org 3calculated by the following equation: organ coefﬁcient = [organ
wet weight (g)/body weight (g)] × 100% (Zhang et al., 2014b).
Analysis of EPO, EPO Receptor (EPOR),
TPO, TPO Receptor (C-Mpl), GM-CSF, and
GATA-1 in Mice Bone Marrow Nucleated
Cells
One femur was isolated after the sacriﬁce of each mouse. The
attached muscles were removed by gauze polishing. The femur
was brieﬂy soaked in 75% ethanol before washing with
phosphate buffered solution for three times under aseptic
conditions. The bone marrow cells were washed out of the
femur with phosphate buffered solution several times and
ﬁltered with a 0.4 mm diameter needle. The bone marrow cell
suspensions were separated with mice lymphocyte separation
solution to prepare the bone marrow nucleated cells, after which
800 ml of RNAiso Plus kit (TaKaRa, Kusatsu, Japan) was added
before storage at −80°C until real-time quantitative polymerase
chain reaction (RT-qPCR) analysis was done. Total RNA from
the bone marrow nucleated cells was extracted using the RNAiso
Plus kit (TaKaRa, Kusatsu, Japan) in accordance with the
manufacturer's protocols. Then total RNA (microgram) was
reverse-transcribed into cDNA using a Primer-Script First
Strand cDNA synthesis kit (TaKaRa, Kusatsu, Japan) (Yang
et al., 2018). The design of gene-speciﬁc primers was done
with Primer 5.0 software based on published mice sequences
from the GeneBank/National Center for Biotechnology
Information database and they were synthesized by TsingKe
Biological Technology (Beijing, China). The nucleotide
sequences primers used for PCR were shown in Table 1. The
RT-qPCR program was conducted using a Light Cycler® 96
System (DBI® Bioscience, Ludwigshafen, Germany).
Thermocycling parameters included an initial phase of 95°C
for 2 min followed by 40 cycles of 95°C for 10 s and 60°C for 32 s.
The relative gene expression values were calculated with the
2−△△Ct method (Chen et al., 2017).
Pathway and Targets Analyses
Prediction
Based on previous research (Xiong et al., 2019), 20 compounds
including ginsenosides of F2, Rb1, Rb2, Rb3, Rc, Rd, Re, Rg1, Rh2,TABLE 1 | Primers sequence and parameters for a reference gene and six target genes.
Gene Gene ID GenBank Accession Primer sequence Forward/Reverse (5′-3′) Product (bp)
EPO 13856 NC_000071.6 F: TGGAGGTGGAAGAACAGG
R: GCAGTGAAGTGAGGCTACG
165
EPOR 13857 NC_000075.6 F: CGCTTGGAAGACTTGGTGTGT
R: CTCACCCTCGAGCTGGTATGA
90
TPO 22018 NC_000078.6 F: CCAGACGGAACAGAGCAAG
R: CTGTCCTCGTGCTGCCAT
82
c-Mpl 17480 NC_000070.6 F: CCTGCACTGGAGGGAGGTCT
R: GGCTCCAGCACCTTCCAGTC
135
GM-CSF 12981 NC_000077.6 F: AAGCCCTAAACCTCCTGGATG
R: GCCTACCAGACATACTGCCCCCC
142
GATA-1 14460 NC_000086.7 F: GGAGGGACAGGACAGGTCACT
R: GTTTGCTGACAATCATTCGCTT
110
b-actin 11461 NC_000071.6 F: CCAGCCTTCCTTCTTGGGTAT
R: CATAGAGGTCTTTACGGATGTCAAC
97January 2020 | Volume 10 | Article 1578
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and 20(S)-Rh1; and notoginsenosides of C, R1, and R2 reported in
SPN were selected to construct the network. “The chemical
structures of the composite compounds in SPN were obtained
from traditional Chinese medicine Database@Taiwan (TDT) or
drawn with ChemDraw professional 15.0 (Chen, 2011). The
targets of constituents were predicted by the online target
prediction software of Pharmmapper with a criterion of “ﬁt
score” > 4 (http://lilab.ecust.edu.cn/pharmmapper/index.php)
(Wang et al., 2017). Gene and protein targets associated with
the disease of anemia were collected from the Online Mendelian
Inheritance in Man (OMIM) database (Amberger et al., 2015).
Database of Interacting Proteins for protein-protein interactions
(PPI) was employed to identify the possible interactions of the
aforementioned targets. All protein ID codes were converted to
UniProt IDs (Wei et al., 2016).”We used the DAVID (a Database
for Annotation, Visualization, and Integrated Discovery)
Functional Annotation Bioinformatics Microarray Analysis
(https://david.ncifcrf.gov/) for pathway enrichment analysis
and the Kyoto Encyclopedia of Genes and Genomes (KEGG)
to construct the “SPN components-target-anemia” network with
protein-protein interactions information. Three topological
parameters of “degree,” “betweenness centrality” and “close
centrality,” and Cytoscape 4.3 were applied to screen potential
targets for SPN treating anemia (Xiong et al., 2019). These
relevant proteins were put into DAVID to perform gene
ontology terms and KEGG pathway analysis.
Veriﬁcation
Total Protein Extraction and Western Blotting Analysis
Spleen proteins were extracted using RIPA lysis buffer (Solarbio,
Beijing, China) and centrifuged at 12,000 g for 10 min at 4°C.
Protein concentration was assessed using the BCA Protein Assay
Kit (Biosharp, Beijing, China). Samples containing equal
amounts of protein (80 mg) were separated by 10% sodium
dodecyl sulfate-polyacrylamide gel electrophoresis and then
transferred to 0.45 mm polyvinylidene diﬂuoride membranes
(Biosharp, Beijing, China). The non-speciﬁc binding sites on
the membrane were then blocked with 5% fresh non-fat dry milkFrontiers in Pharmacology | www.frontiersin.org 4in Tris buffered saline TBS with Tween (10 mM Tris, 150 mM
NaCl, pH7.4) with 0.1% Tween 20) for 2 h. Subsequently, they
were incubated with primary antibodies (anti-IL-2, anti-STAT1,
anti-SHP2, anti-JAK1, and anti-p-JAK1; 1:1000 dilution; Abcam,
Cambridge, UK) and primary b-actin antibody (1:1,000 dilution;
abmart, Shanghai, China) overnight at 4°C, respectively. After
this, the membrane was washed followed by three 10 min washes
in TBST, and then incubated with anti−mouse secondary
antibody (1:2000 dilution; Cell Signaling Technology,
Shanghai, China) for 2 h at room temperature followed by
three 10 min washes in TTBS. Finally, the chemiluminescent
signals were observed with a multifunctional gel imaging system
(Bio-Rad, USA) and densitometry for immunoreactive bands
was performed with National Institutes of Health software
(Image J).
Analysis of IL-2, STAT1, SHP2, p-JAK1, Bcl-2, Bcl-XL, c-
Myc, and p21 in Mice Spleen by RT-qPCR
The analysis method refers to item 2.5. IL-2, STAT1, SHP2, p-
JAK1, Bcl-2, Bcl-XL, c-Myc, and p21 genes sequence synthesized
by TsingKe Biological Technology (Beijing, China), and primers
sequence are shown in Table 2.
Statistical Analyses
All data are expressed as means ± standard deviation. SPSS 21.0
software (Statistical Program for Social Sciences, SPSS Inc, USA)
was applied to carry out the two-tailed unpaired t-test. A value of
P < 0.05 was considered to indicate a signiﬁcant difference. A
value of P < 0.01 was considered to indicate a highly signiﬁcant
difference. Quantitative gene expressions were determined by
RT-qPCR and histograms were drawn by GraphPad Prism 7
software (GraphPad Software, USA).RESULTS
General Behavior of Mice
The change of general behavior of mice can reﬂect the
occurrence and recovery of BDS of mice to certain degreeTABLE 2 | Primers sequence and parameters for IL-2, STAT1, SHP2, p-JAK1, Bcl-2, Bcl-XL, c-Myc, and p21 genes.
Gene Gene ID GenBank Accession Primer sequence Forward/Reverse (5′-3′) Product (bp)
IL-2 16183 NC_000069.6 F: CCTGAGCAGGATGGAGAATTACA
R: TCCAGAACATGCCGCAGAG
141
STAT1 20846 NC_000067.6 F: AAACTGCCAACTCAACACCTCT
R: AGACCACCTCTCTTCCTGTCGT
107
SHP2 19247 NC_000071.6 F: ATCCGCCAGAAGTCATTCACC
R: TTTGATCATACCAGGGTCGTT
178
p-JAK1 16451 NC_000070.6 F: TGGAGGTAACCACATAGC
R: CCGAGAACCCAAATAGTC
250
Bcl-2 12043 NC_000067.6 F: CCTGTGCCACCATGTGTCCATCC
R: GCTGAGAACAGGGTCTTCAGAGAC
400
Bcl-XL 12125 NC_000068.7 F: TGGATCTCTACGGGAACAATGC
R: GTGGCTGAAGAGAGAGTTGTGG
197
c-Myc 17869 NC_000081.6 F: TCAAGAGGTGCCACGTCTCC
R: TCTTGGCAGCAGGATAGTCCTT
81
p21 12575 NC_000083.6 F: GTGTGCCGTTGTCTCTTCGG
R: CTCAGGTAGACCTTGGGCAG
188January 2020 | Volume 10 | Article 1578
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group became sluggish, exhausted and somnolent, along with
weight loss, sparse hair, pale ears and tail, and loss of appetite.
Those symptoms were consistent with the description of BDS in
Chinese medicine (Ji et al., 2017). In contrast, mice in the control
group and BDS-induced mice treated with FEJ or SPN were
relatively vigorous and strong, presenting thick and lustrous hair,
pink and moist nose and lips, round and pink tail, gained weight
and better appetite.
Blood Routine Test
After the administration of saline, FEJ or SPN for 12 days, the
quantities of WBC, RBC, Hb, and PLT from the peripheral blood
of mice were determined (Figure 1). Compared to the control
group, the levels of WBC, RBC, Hb, and PLT in the model group
were decreased signiﬁcantly (p < 0.01), indicating the anemia
model was established successfully. Comparison within the
model group shows that WBC, RBC, Hb and PLT levels in
mice treated with FEJ and H-SPN were increased signiﬁcantly
(p < 0.01 or p < 0.05). In particular, all three doses (H, M, and L)
of SPN signiﬁcantly improved the level of WBC (p < 0.01). RBC
and Hb levels in mice treated with M-SPN and L-SPN were not
signiﬁcantly increased.
Organ Coefﬁcients
The results for organ coefﬁcients are shown in Figure 2.
Compared to the control group, the liver and kidney of the
model group were relatively small, but the spleen was abnormallyFrontiers in Pharmacology | www.frontiersin.org 5enlarged. Except for the spleen coefﬁcient, there was no
signiﬁcant difference in other organ coefﬁcients between the
experimental groups (model, FEJ, H-SPN, M-SPN, and L-SPN
group) and the control group. Compared to the control group,
the spleen coefﬁcient of the model group was increased
signiﬁcantly (p < 0.01). Comparison within the model group
shows that the spleen coefﬁcients of the FEJ and H-SPN groups
were decreased signiﬁcantly (p < 0.01), the M-SPN group was
decreased signiﬁcantly (p < 0.05), whereas there was no
signiﬁcant difference for the L-SPN group. According the
results, SPN induces a reversing effect on the enlargement of
spleen in a dose-dependent way.
Effect of SPN on EPO, EPOR, TPO, c-Mpl,
GM-CSF, and GATA-1 in Mice Bone
Marrow
The effects of FEJ and SPN on the mRNA expression of
hematopoietic function-related cytokines in the bone marrow of
mice is shown in Figure 3. Compared to the control group, the
levels of EPO, EPOR, TPO and c-Mpl in the model group were
increased signiﬁcantly (p < 0.01 or p < 0.05). Comparison within
model group shows that the levels of the above cytokines in mice
treated with FEJ and H-SPN were increased signiﬁcantly (p < 0.01).
Increases to different degrees were also seen in the M-SPN and L-
SPN groups. Compared to the control group, the levels of GM-CSF
and GATA1 in the model group were decreased signiﬁcantly (p <
0.01 or p < 0.05). Comparison within the model group shows that
both cytokines were signiﬁcantly increased in mice treated with FEJ,FIGURE 1 | The blood parameters of the control and model mice after treatment with saline solution (model), FEJ and different amounts doses of SPN. (A) The
number of WBC. (B) The number of RBC. (C) The content of Hb. (D) The number of PLT. Each value represents the mean ± SD (n = 10); *p < 0.05 and **p < 0.01,
compared to the control group; ▲p < 0.05 and ▲▲p < 0.01, compared to the model group.January 2020 | Volume 10 | Article 1578
Zhang et al. Mechanism of SPN Attenuating AnemiaFIGURE 2 | The organ coefﬁcients of control and model mice after treatment with saline solution (model), FEJ and different doses of SPN. (A) The liver coefﬁcient.
(B) The spleen coefﬁcient. (C) The kidney coefﬁcient. Each value represents the mean ± SD (n = 10); **p < 0.01, compared to the control group; ▲p < 0.05 and
▲▲p < 0.01, compared to the model group.FIGURE 3 | The mRNA expression of (A) EPO, (B) EPOR, (C) TPO, (D) c-Mpl, (E) GM-CSF, and (F) GATA1 in control and model mice after treatment with saline
solution (model), FEJ and different doses of SPN. Each value represents the mean ± SD (n = 10); *p < 0.05 and **p < 0.01, compared to the control group;
▲p < 0.05 and ▲▲p < 0.01, compared to the model group.Frontiers in Pharmacology | www.frontiersin.org January 2020 | Volume 10 | Article 15786
Zhang et al. Mechanism of SPN Attenuating AnemiaH-SPN, M-SPN and L-SPN (p < 0.01 or p < 0.05). The mRNA
expression levels of these hematopoietic related cytokines were
changed in a SPN dose-dependent manner.
Pathway and Targets Analyses
Prediction
According to the pathway enrichment analysis, the JAK-STAT
signaling pathway was predicted to be one of the most enriched
pathways (Figure S1). Based on the KEGG analysis, three anemia-
related targets are involved in the pathway and corresponding
active constituents in PN are predicted and shown in Table 3
(Xiong et al., 2019). Another kinase protein, JAK1, between IL-2
and STAT1 or SHP2, also plays a signiﬁcant pivotal role in the
JAK-STAT pathway (Figure 4). Therefore, the expression of IL-2,
JAK1, p-JAK1, and STAT1 proteins in BDS mice was investigated
in the following analysis. In addition, the mRNA expression of
downstream cytokines including Bcl-2, Bcl-XL, c-Myc, and p21
related to the cell cycle was investigated based on the prediction
and reference studies (Fröjmark et al., 2010; Karimian et al., 2016).
Western Blotting Analysis
The protein expression of JAK1, p-JAK1, STAT1, SHP2, and IL-
2 in the spleen of mice in each group is shown in Figure 5. The
results of the gray scale analysis are shown in Table 4. According
to the results, there was no signiﬁcant difference in JAK1
expression among the groups (p > 0.05). The expression level
of p-JAK1 in the model group was signiﬁcantly higher than in
the control group (p < 0.01). Both FEJ, H-, and M-SPN result in
signiﬁcantly lower protein expression levels than in the model
group (p < 0.01). Compared to the control group, the expression
levels of protein STAT1, SHP2 and IL-2 in the model group were
signiﬁcantly decreased (p < 0.01 or p < 0.05). Comparison within
the model group shows that the expression levels of the protein
IL-2 after treatment with FEJ, H-SPN, M-SPN or L-SPN were
signiﬁcantly increased (p < 0.01 or p < 0.05). The expression
levels of the protein STAT1 and SHP2 in FEJ and H-SPN groups
were signiﬁcantly higher than those in the model group, and the
differences were statistically signiﬁcant (p < 0.01 or p < 0.05),
while those for in M-SPN and L-SPN groups were not
statistically signiﬁcant (p > 0.05).
Quantiﬁcation of IL-2, STAT1, SHP2 and p-JAK1 by
RT-qPCR in Mice Spleen
The expression of IL-2, STAT1, SHP2 and p-JAK1 mRNA in the
spleen of mice is shown in Figure 6. Compared to the control
group, the expression of IL-2 and SHP2 mRNA in the model
group was signiﬁcantly down-regulated (p < 0.01). ComparisonFrontiers in Pharmacology | www.frontiersin.org 7within the model group shows that after treatment with FEJ or
different dose of SPN, the expression of IL-2 and SHP2 mRNA in
the administered groups was increased to varying degrees in a
dose-dependent manner. There was no signiﬁcant difference in
the expression of IL-2 and SHP2 between the L-SPN group and
the model group (p > 0.05), others are statistically signiﬁcant
(p < 0.01). Compared to the control group, the expression of
STAT1 and p-JAK1 mRNA in the model group was signiﬁcantly
up-regulated (p < 0.01). Comparison within the model group
shows that after treatment with FEJ or different dose of SPN, the
expression of STAT1 and p-JAK1 mRNA in the administered
groups was decreased and negatively related to the drug
concentration. There was no signiﬁcant difference in the
expression of STAT1 and p-JAK1 between the L-SPN group
and the model group (p > 0. 05). There was no signiﬁcant
difference in the expression of p-JAK1 between the M-SPN
group and the model group (p > 0. 05). And there was
signiﬁcant difference between the other groups (p < 0. 01).
Quantiﬁcation of JAK1-STAT1 Downstream
Cytokines in Mice Spleen by RT-qPCR
The expression of Bcl-2, Bcl-XL, c-Myc, and p21 mRNA in the
spleen of mice is shown in Figure 7. Compared to the control
group, the expression of Bcl-2 and Bcl-XL mRNA in the model
group was highly signiﬁcantly down-regulated (P < 0.01).
Comparison within the model group shows that after treatment
with FEJ or different dose of SPN, the expression of Bcl-2 and Bcl-
XL mRNA in the administered group was increased to varying
degrees in a dose-dependent manner. Except that there was no
signiﬁcant difference between the Bcl-2 mRNA of L-SPN and the
model group (p > 0.05), and the other groups were statistically
signiﬁcant (p < 0.01). Compared to the control group, the
expression of c-Myc and p21 mRNA in the model group was
highly signiﬁcantly up-regulated (p < 0.01). Comparison within the
model group shows that after treatment with FEJ or different dose of
SPN, the expression of c-Myc and p21 mRNA in the administered
group decreased and was negatively related to the drug
concentration. Except that there was no signiﬁcant difference
between the L-SPN and the model group (p > 0.05), and the
other groups were statistically signiﬁcant (p < 0.01).DISCUSSION
According to traditional Chinese medicine theory, the
pathogenesis of blood deﬁciency could be the disharmony ofTABLE 3 | The information of three targets and their corresponding active constituents involved in JAK-STAT signal pathway predicted by KEGG.
Gene ontology
terms
Protein name Abbreviations Closeness cen-
trality
Degree Betweeness cen-
trality
Constituent predicted
P60568 Interleukin-2 IL-2 0.2404 4 0.0056 Ginsenosides Rb2 and 20
(R)-Rg3
Q06124 Tyrosine-protein phosphatase non-receptor
type 11
SHP2 0.2812 6 0.0078 Ginsenosides Rd, Rh4,
and Rk3
P42224 Signal transducer and activator of transcription
1-alpha/beta
STAT1-a/b 0.2188 2 0.0024 Notoginsenoside CJanuary 2020 | Volume 10 | Article 1578
Zhang et al. Mechanism of SPN Attenuating AnemiaYin-Yang, qi deﬁciency, blood stasis, and the dysfunction of
internal organs. Therefore, herbal medicines which can nourish
qi and blood, as well as invigorate the spleen and kidney are often
used in the clinic to treat blood deﬁciency and anemia (Hijikata
et al., 2009; Wu et al., 2013; Sun et al., 2016). For example, FEJ, the
positive control in the study, is a widely used immune-boostingFrontiers in Pharmacology | www.frontiersin.org 8traditional Chinese formula which has been clearly conﬁrmed to
promote the recovery of bone marrow hemopoietic activity and
enhance the immune function (Liu et al., 2014; Shen et al., 2016).
While for SPN, another tonic and hemostatic drug used for more
than 400 years, the possible mechanism of the “blood-tonifying”
effect is unclear yet. After the modeling, there was an obvious
change in the appearance of mice, including hair loss, movement
retardation, and weight loss, with the signiﬁcant decrease in the
peripheral WBC, RBC, Hb, and PLT, which are characteristic
clinical manifestations of blood deﬁciency as well as anemia (Sun
et al., 2016). With the H-SPN and FEJ treatments, the decrease of
peripheral blood cells was reversed signiﬁcantly (Figure 1),
suggesting that H-SPN and FEJ could enhance the
hematopoietic effect of mice with BDS, consistent with the
traditional use of SPN and FEJ to tonify the blood (Gu et al.,
2015). Meanwhile, M-SPN and L-SPN could not increase the
numbers of RBC, Hb and PLT signiﬁcantly, suggesting that a
higher dosage of SPN was required to achieve a more obvious
therapeutic effect, which was consistent with our previous study
(Xiong et al., 2017a). Another diagnostic consideration for anemia
is the enlarged size of spleen, which is one of the most common
and early organs to be affected in different types of anemia
(Dhaliwal et al., 2004; Alsalem, 2011). It is generally accepted
that the hematopoietic deﬁciency is associated to a massive
migration of bone marrow progenitor cells out of the marrow,
via the blood, leading to an accumulation in the spleen (QueirozFIGURE 5 | The expression of predicted target protein by Western blot.
Lanes 1–6 represent control, model, FEJ, H-SPN, M-SPN, and L-SPN group,
respectively.FIGURE 4 | Target proteins (IL-2, SHP2, and STAT1) predicted to be involved in the JAK-STAT pathway and the downstream cytokines (Bcl-2, Bcl-XL, c-Myc, and
p21). IL-2, interleukin-2; JAK1, janus kinase-1; SHP2, tyrosine-protein phosphatase non-receptor type 11; GRB, growth factor receptor-bound protein; SOS,
guanine nucleotide exchange factor; STAT1, signal transducer and activator of transcription; Bcl-2, B-cell lymphoma-2; Bcl-XL, Bcl-2 like 1; c-Myc, v-myc avian
myelocytomatosis viral oncogene homolog; and p21, cki.January 2020 | Volume 10 | Article 1578
Zhang et al. Mechanism of SPN Attenuating Anemiaet al., 2004). And the pooling of RBCs in the enlarged spleen can
exacerbate the syndrome of anemia in turn (Gaspar et al., 2015).
Therefore, the decline of RBCs in circulation and anemia can be
both correlated with the extent of the enlargement of the spleen
(Wagner et al., 2000). According to Figure 3, the weight and size of
spleen in the model group were increased. While the spleen of
mice treated with FEJ, H-SPN, and M-SPN was kept from
enlarging compared to the model group (Figure 2C). It indicates
that FEJ, H-SPN, and M-SPN could alleviate the side effects of
chemotherapy on the spleen and protect the immune organ.
The process of blood cell formation, by which a small number
of self-renewing stem cells give rise to lineage committed
progenitor cells that subsequently proliferate and differentiate
to produce the circulating mature blood cells, is regulated by a
series of related hematopoietic related cytokines (Sieff, 1987).
Hematopoietic growth factors (HGFs) including EPO, TPO,
GM-CSF, and IL-3 are cytokines involved in the regulation ofFrontiers in Pharmacology | www.frontiersin.org 9hematopoiesis (Ferretti et al., 2006; Genova et al., 2016). Among
them, EPO is a glycoprotein hormone and a major agonist for the
production of WBC (Franke et al., 2013). EPO binds to its
receptor EPOR, activates the downstream JAK-STAT signaling
pathway, promotes the growth and differentiation of erythroid
progenitor cells, inhibits their apoptosis, and mobilizes
hematopoietic stem cells (HSCs) (Madonna et al., 2009; Elliott
et al., 2014). The results in Figures 3A, B show that the
expressions of EPO and EPOR mRNA in the model group was
higher than those in the control group, suggesting that the
chemotherapy-induced anemia caused a feedback increase in
EPO content, and then induced the expression of EPOR. This is a
compensatory mechanism. Due to the damage of chemotherapy
drugs to bone marrow cells, the reactivity of reactive cells to
HGFs is reduced. So a higher concentration of HGFs is required
to promote the recovery of hematopoietic function, which is
consistent with the above literature reports. While after treatingFIGURE 6 | The mRNA expression of (A) IL-2, (B) STAT1, (C) SHP2, and (D) p-JAK1 in control and model mice after treatment with saline solution (model), FEJ
and different doses of SPN. Each value represents the mean ± SD (n = 10); *p < 0.05 and **p < 0.01, compared to the control group; ▲p < 0.05 and ▲▲p < 0.01,
compared to the model group.TABLE 4 | Gray value ratio of predicted target proteins/b-actin by Western blot.
JAK1 p-JAK1 STAT1 SHP2 IL-2
Control 1.821 ± 0.0761 1.0237 ± 0.0563 1.1813 ± 0.1527 1.7962 ± 0.137 1.5006 ± 0.08375
Model 1.8976 ± 0.0921 1.2527 ± 0.0469** 0.7504 ± 0.0973* 0.5483 ± 0.0937** 1.07862 ± 0.0297*
FEJ 1.9013 ± 0.0631 0.823 ± 0.731▲▲ 1.2875 ± 0.1268▲ 1.9767 ± 0.1403▲▲ 1.7025 ± 0.085▲▲
H-SPN 1.8356 ± 0.0821 0.9651 ± 0.3758▲▲ 0.8653 ± 0.1348▲ 1.1301 ± 0.1335▲ 1.2779 ± 0.0574▲
M-SPN 1.8445 ± 0.0824 1.0014 ± 0.5728▲▲ 0.6993 ± 0.0838 1.0099 ± 0.061 1.2375 ± 0.0543▲
L-SPN 1.8713 ± 0.0762 1.2352 ± 0.3862 0.7571 ± 0.1019 1.0894 ± 0.0208 1.2104 ± 0.066▲January 2020 | VoluEach value represents the mean ± SD (n = 10); *p < 0.05 and **p < 0.01, compared with the control group; ▲p < 0.05 and ▲▲p < 0.01, compared with the model group.me 10 | Article 1578
Zhang et al. Mechanism of SPN Attenuating AnemiaFIGURE 8 | (A) Changes of body parameters and cytokines in BDS mice compared to the control group. (B) Changes of body parameters and cytokines in SPN
administration groups mice compared to the model group. IL-2, interleukin-2; JAK1, janus kinase-1; SHP2, tyrosine-protein phosphatase non-receptor type 11;
GRB, growth factor receptor-bound protein; SOS, guanine nucleotide exchange factor; STAT, signal transducer and activator of transcription; Bcl-2, B-cell
lymphoma-2; Bcl-XL, Bcl-2 like 1; c-Myc, v-myc avian myelocytomatosis viral oncogene homolog; p21, cki.FIGURE 7 | The mRNA expression of (A) Bcl-2, (B) Bcl-XL, (C) c-Myc, and (D) p21 in control and model mice after treatment with saline solution (model), FEJ and
different doses of SPN. Each value represents the mean ± SD (n = 10); *P < 0.05 and **P < 0.01, compared to the control group; ▲P < 0.05 and ▲▲P < 0.01,
compared to the model group.Frontiers in Pharmacology | www.frontiersin.org January 2020 | Volume 10 | Article 157810
Zhang et al. Mechanism of SPN Attenuating Anemiawith the drugs, the expression of EPO and EPOR mRNA in the
administration groups (FEJ, H-SPN, M-SPN, and L-SPN groups)
was higher than that in model group, indicating that FEJ and
SPN could promote the recovery of erythropoiesis by promoting
the synthesis and secretion of EPO in mice bone marrow. A
similar tendency was also observed in the level change of TPO
and its receptor c-Mpl in the bone marrow of mice (Figures
3C, D), the former of which is the most important regulator of
platelet production, as well as a major cytokine required for the
development of HSCs, monocytes, granulocytes, mast cells and
dendritic cells (Chen, 2004; Kirshenbaum et al., 2004). After
administration of FEJ and SPN, the expression of TPO and c-
Mpl mRNA in bone marrow was signiﬁcantly increased, which
would be beneﬁcial to promote the recovery of megakaryocytes
hematopoiesis and increase the number of peripheral PLT in
mice with BDS. Another important HGF is GM-CSF, whichFrontiers in Pharmacology | www.frontiersin.org 11mainly acts on HSCs/HPCs and bone marrow stromal cells or
ﬁbroblasts, and plays an important role in regulating
hematopoiesis and leukocyte formation (Kimura et al., 1997;
Waller, 2007). The results in Figure 3E showed that APH and
CY signiﬁcantly inhibited the expression of GM-CSF mRNA,
which was increased signiﬁcantly after the administration of FEJ
and SPN. It indicated that FEJ and SPN could inhibit the
cytotoxicity of CY and APH to some extent. GM-CSF level was
induced to increase, promoting the recovery of granulocytic
hematopoietic function. We also investigated the change of
GATA1, a necessary transcription factor for the development
and maturation of normal erythrocytes. The increased
expression of GATA1 mRNA after treating FEJ and SPN was
consistent with the above mentioned cytokines (Figure 3F).
From the results of responses of the hematinic function-related
cytokines, we noted that the expression of themwere closely relatedFIGURE 9 | The six compounds corresponding to the three targets involved in the JAK-STAT signal pathway related to the treatment of BDS with SPN.
(A) Ginsenosides Rh4, (B) ginsenosides Rk3, (C) ginsenosides Rb2, (D) ginsenosides 20(R)-Rg3, (E) ginsenosides Rd, and (F) notoginsenoside C.January 2020 | Volume 10 | Article 1578
Zhang et al. Mechanism of SPN Attenuating Anemiato the signal pathway of JAK-STAT, which plays a critical role in
transduction of extracellular signals from cytokines and growth
factors involved in hematopoiesis, immune regulation and
inﬂammation (Vainchenker and Constantinescu, 2013; Chen
et al., 2016). According to our previous analysis of network
pharmacology, JAK-STAT was also predicted to be one of the
major pathways related to the treatment of anemia with SPN
(Figure S1). IL-2, STAT 1, and SHP2 in Figure 4, were predicted
to be themajor three targets involved in the JAK-STAT pathway to
treat anemia (Xiong et al., 2019). To verify the prediction, we
investigated the effect of SPN on the expression of the three targets
and also the downstream cytokines of JAK-STAT including Bcl-2,
Bcl-XL, c-Myc, and p21. According to the results, the treatment by
APH and CY could signiﬁcantly inhibit the expression of IL-2 and
SHP2 proteins (Figure 5) and the corresponded mRNA's (Figures
6A, C). Since IL-2 is a Th1 type cytokine secreted by T cells
(Vafadari et al., 2012) and SHP2 plays an up-regulation role in
the development and function of hematopoietic cells (Kratz et al.,
2007; Zhu et al., 2011), the chemotherapy-induced anemia could be
related to the development of immunosuppression and cytotoxicity
on hematopoietic cells. After the drug administration, the
expression of IL-2 and SHP2 was increased, suggesting that FEJ
and SPN could make a positive effect on enhancing the T cell
immunity and reducing the cytotoxicity. Meanwhile, it was
reported that SHP2 directly mediates many cytokines and growth
factor receptors like GM-CSF and EPO receptors (Myers et al.,
1998). The increased mRNA expression of GM-CSF and EPOR
shown in Figure 3 could be partly attributed to the up-regulation
role of SHP2 intervened by SPN. The role of drugs on another
important signal transducer and activator of transcription, STAT 1,
was investigated by Western blot and RT-qPCR. As shown in
Figure 6B, the chemotherapy-induced the expression of STAT 1
mRNA,whichwasdecreased inadose-dependentwaywhen treated
with SPN. However, the activation of STAT1 protein level (Figure
5)was inconsistentwith itsmRNAexpression.Thismight bedue to
that the post-transcriptional RNA and the binding sites of
regulatory proteins changed the mode of translation and then
affected the expression of proteins. Such phenomenon was also
investigated in previous studies (Saunders et al., 2007; Nicoloso
et al., 2016). Another possible explanation may be that the post-
translational modiﬁcation led to a decrease in the stability or half-
life of the protein. Also, the activity of JAK1 and its phosphorylated
form, the enzymes essential for the receptor signaling located in the
upstream of STAT1, was investigated. According to the results, the
treatment of drugs made no signiﬁcant effect on the expression of
JAK1, whereas the expression of p-JAK1 was increased after the
chemotherapy and then decreased after treating with FEJ and H-
SPN. It suggested that FEJ andH-SPNmight regulate the hematinic
function through phosphorylating JAK1.
Besides the above targets involved in the pathway (Figure 8),
network pharmacology also provides the chemical information
related to the efﬁcacy of SPN, which is therefore beneﬁcial to
uncovering the interactions between active constituents in SPN and
the complex syndrome systems (Tao et al., 2013; Sheng et al., 2014).
By the analysis of network pharmacology, six compounds in SPN
were predicted to be the anti-anemia ones corresponding to the threeFrontiers in Pharmacology | www.frontiersin.org 12targets involved in the JAK-STAT signal pathway, which were
ginsenosides Rh4, Rk3, Rb2, 20(R)-Rg3, Rd, and notoginsenoside C
(Figure 9). Differences in ginsenoside structure which include the
type, position, and number of sugarmoieties attached by a glycosidic
bond can characteristically inﬂuence the biological responses (Teng
et al., 2017; Chen et al., 2019). Among them, 20(R)-Rg3, Rh4, andRk3
showed increased levels alongwith the duration of steaming and had
a key role in the activities of SPN in our previous study (Xiong et al.,
2017b). Zhou et al. (2016) reported that Rg3 helped repair blood
disorders such as anemia, leukopenia, and thrombocytopenia. 20(R)-
Rg3 could also stimulated the production of IL-2 and enhance the
cellular immunity in tumor-bearing mice (Wu et al., 2014), which
was consistent with our result of IL-2 expression. Ginsenosides Rh4
and Rk3 were considered to be new therapeutic drugs for treating
anemia since Rk3 promoted bone marrow and extramedullary
hematopoiesis while Rh4 promoted extramedullary hematopoiesis
(Wei et al., 2018).Different fromRg3, Rb2 andRdhave an addition of
one glucose moiety and two glucose moieties attached at C-20
position. Rb2 could protect the hematopoietic system from the
irradiation-caused injury and promote the synthesis of serum
protein and DNA of marrow cells (Lee et al., 2011; Zhang et al.,
2017).GinsenosidesRd could regulate the expression of Bcl-2 (Wang
et al., 2013). Notoginsenside C was only mentioned in a few reports
(Yoshikawa et al., 2001; Chen et al., 2010) which could have the anti-
tumor and immunological adjuvant activity. In further studies, the
effects of those constituents and related mechanism will be
investigated and conﬁrmed.
Bcl-2, Bcl-XL, c-Myc, and p21 are cell cycle-related factors of
JAK1-STAT1. SPN could act on the JAK1-STAT1 signaling
pathway and simultaneously affect the downstream cytokines,
improving the cell apoptosis of mice with BDS. According to
Figure 7A, the expression of Bcl-2 was up-regulated along with
the dose increase of SPN, which could maintain the survival and
proliferation of erythroid progenitor cells when GATA-1 was
reduced in the model of anemia (Figure 3F) (Kapur and Zhang,
2001). Another anti-apoptotic protein of Bcl-XL was also up-
regulated when treating with SPN (Figure 7B), which might be
due to the mediation of GATA1, EPO and TPO through the JAK/
STATs pathway, supporting the survival of hematopoietic cells
(Chiba et al., 1991; Kitajima, 2006). c-Myc and p21, the expression
ofwhichwereoften increased inhematologicalmalignancies caused
by BDS or DNA damage, were both down-regulated signiﬁcantly
after giving SPN (Figure 7C), suggesting that SPNmight attenuate
anemiaby inhibiting thearrest of cell cycle becauseofDNAdamage.
Therefore, the expression of various hematopoietic factors could be
closely related to the cell apoptosis. This is consistentwith the report
of Ćmielová and Řezáčová, (2011).
CONCLUSIONS
The hematopoietic effect andmechanism of SPN onmice with BDS
was studied at three levels. Firstly, SPN reverted the decrease in the
number of peripheral blood cells and prevented the enlargement of
the extramedullary hematopoietic organ of spleen. Secondly, SPN
promoted the expression of related hematopoietic cytokines
including EPO, EPOR, TPO, c-Mpl, GM-CSF, and GATA-1 inJanuary 2020 | Volume 10 | Article 1578
Zhang et al. Mechanism of SPN Attenuating Anemiabone marrow nucleated cells of mice. Thirdly, SPN was involved in
the activation of JAK-STAT signaling pathway, through regulating
the targets expression of IL-2, p-JAK, STAT1, and SHP, and also the
downstream cell cycle factors of Bcl-2, Bcl-XL, c-Myc, and p21
(Figure 8). SPN could inﬂuence the cell cycle and possibly the
apoptosis process, enabling the damaged cells to obtain a favorable
survival condition in a blood deﬁciency environment. The present
study provides further guidance for developments in the clinical use
and as well as provides clues for drug development of SPN.DATA AVAILABILITY STATEMENT
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